Published in Breast J on September 25, 2012
What is publication? Lancet (2006) 3.02
Breast cancer mortality in organised mammography screening in Denmark: comparative study. BMJ (2010) 2.99
Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study. Lancet Oncol (2011) 2.45
Overdiagnosis of breast cancer after 14 years of mammography screening. Tidsskr Nor Laegeforen (2012) 1.63
Why mammography screening has not lived up to expectations from the randomised trials. Cancer Causes Control (2011) 1.41
Norwegian mammography screening - numerous self-contradictions in the evaluation. Tidsskr Nor Laegeforen (2016) 1.38
Overdiagnosis in organised mammography screening in Denmark. A comparative study. BMC Womens Health (2009) 1.35
Biases in estimates of overdetection due to mammography screening. Lancet Oncol (2008) 1.24
Spontaneous regression of cancerous tumors detected by mammography screening. JAMA (2004) 1.20
Flawed inferences about screening mammography's benefit based on observational data. J Clin Oncol (2008) 1.17
Influence of mammography screening on use of mastectomies in Denmark. Acta Oncol (2014) 1.05
Social inequalities in mortality: changes in the relative importance of income, education and household size over a 27-year period. Eur J Public Health (2005) 1.01
A decline in breast-cancer incidence. N Engl J Med (2007) 1.01
An investigation of the apparent breast cancer epidemic in France: screening and incidence trends in birth cohorts. BMC Cancer (2011) 0.99
Is birth history the key to highly educated women's higher breast cancer mortality? A follow-up study of 500,000 women aged 35-54. Int J Cancer (2005) 0.98
The value of autopsies for determining the cause of death. Tidsskr Nor Laegeforen (2012) 0.97
Chain of care for patients who have attempted suicide: a follow-up study from Bærum, Norway. BMC Public Health (2011) 0.94
Reduction in mortality from breast cancer: decrease with screening was marked in younger age group. BMJ (2005) 0.92
Surgical mortality at 30 days and complications leading to recraniotomy in 2630 consecutive craniotomies for intracranial tumors. Neurosurgery (2011) 0.89
Effect of mammography screening on surgical treatment for breast cancer in Norway: comparative analysis of cancer registry data. BMJ (2011) 0.88
Breast cancer awareness month. Still awaiting screening facts. BMJ (2010) 0.86
Changes in mental health services and suicide mortality in Norway: an ecological study. BMC Health Serv Res (2011) 0.85
Changes in institutional psychiatric care and suicidal behaviour: a follow-up study of inpatient suicide attempters in Baerum, Norway. Soc Psychiatry Psychiatr Epidemiol (2009) 0.81
The benefits and harms of breast cancer screening. Lancet (2013) 0.81
Breast screening: why estimates differ by a factor of 20-25. J Med Screen (2010) 0.79
Apolipoprotein E allelotype is associated with neuropathological findings in Alzheimer's disease. Virchows Arch (2015) 0.78
Loss of lysosomal membrane protein NCU-G1 in mice results in spontaneous liver fibrosis with accumulation of lipofuscin and iron in Kupffer cells. Dis Model Mech (2014) 0.78
Do model results suggest spontaneous regression of breast cancer? Int J Cancer (2006) 0.77
Glucocorticoids dexamethasone and hydrocortisone inhibit proliferation and accelerate maturation of chicken cerebellar granule neurons. Brain Res (2011) 0.77
Model of outcomes of screening mammography: spontaneous regression of breast cancer may not be uncommon. BMJ (2005) 0.77
Overdiagnosis of invasive breast cancer due to mammography screening. Ann Intern Med (2012) 0.77
The Two-County breast screening trial cannot provide a reliable estimate of the effect of breast cancer screening. Radiology (2012) 0.76
[Re: Mammography screening should be discontinued]. Tidsskr Nor Laegeforen (2014) 0.75
[Re: Melanoma incidence on the rise again]. Tidsskr Nor Laegeforen (2015) 0.75
[Is overdiagnosing with 50 percent in mammography screening acceptable?]. Tidsskr Nor Laegeforen (2007) 0.75
[P-H. Zahl replies]. Tidsskr Nor Laegeforen (2013) 0.75
[No effect of organized cervix cancer screening]. Tidsskr Nor Laegeforen (2008) 0.75
Bias when calculating breast cancer mortality after screening mammography in British Colombia. Int J Cancer (2007) 0.75
Constant relative survival rates in Sweden and Norway when adjusting for screening-related overdiagnosis. Int J Cancer (2007) 0.75
Ramifications of screening for breast cancer: definition of overdiagnosis is confusing in follow-up of Malmö trial. BMJ (2006) 0.75
[Re: Why are results of organised mammography screening so difficult to interpret?]. Tidsskr Nor Laegeforen (2014) 0.75
Undeclared motives in withdrawing a publication. Lancet (2007) 0.75
[Estrogen replacement therapy and breast cancer]. Tidsskr Nor Laegeforen (2005) 0.75
Tidsskr Nor Laegeforen (2016) 0.75
More on screening mammography. N Engl J Med (2011) 0.75
[No significant effect of PSA screening]. Tidsskr Nor Laegeforen (2013) 0.75
Declining breast cancer incidence and decreased HRT use. Lancet (2009) 0.75
Postmortem heart weight: relation to body size and effects of cardiovascular disease and cancer. Cardiovasc Pathol (2013) 0.75
[Does organized mammographic screening reduce the breast cancer mortality?]. Tidsskr Nor Laegeforen (2002) 0.75